Medicine for treating respiratory diseases

Abstract

The invention provides a medicine for treating respiratory diseases. The medicine is injection, and each 100ml of the injection contains 0.18-0.22g of sodium aescinate injection, 0.25-0.35g of disodium adenosine triphosphate, 0.08-0.12g of cytochrome C, and the balance of aqueous solvent. According to the invention, by reducing the permeability of blood capillary, raising the tensity and flow velocity of veins, enhancing peripheral blood circulation and lymph circulation, activating and regulating the bioactivity of the respiratory system, and recovering the microbe ecological balance and endogenous immunity and resistance of probiotics, the purpose of treating respiratory diseases is achieved.

Description

technical field [0001] The invention relates to medicine, which is a medicine for treating respiratory diseases. Background technique [0002] Tracheal and respiratory diseases mainly include asthma, tonsillitis, pharyngitis, bronchitis, etc. The incidence of these diseases is relatively high. At present, western medicine is mainly used for treatment. Most of the western medicine treatment programs must use antibiotics, and these diseases are prone to recurrent attacks Diseases, leading to higher and higher levels of antibiotic use. The harm of antibiotics is ubiquitous. Surveys show that after 5 months of antibiotic use in children, the probability of infection resistance rises to 100%. For patients receiving more than 5 kinds of antibiotics, the concurrent drug toxicity rate is as high as 80%. About 60% of the 10,000 deaf-mute patients are caused by the use of antibiotics when they were young. Therefore, on October 14, 2011, the Ministry of Health issued the most stringe...

AI Technical Summary

Problems solved by technology

However, the indiscriminate use of antibiotics has not been fundamentally improved so far

Variations of drug-resistant bacteria emerge in endlessly, and newly developed antibiotics and vaccines cannot catch up with the mutation speed of drug-resistant bacteria

The disorder of microbial flora caused by the indiscriminate use of antibiotics and the proliferation of drug-resistant bacteria induced by it, the chronic non-specific inflammatory lesions of the throat and tracheal wall mucosal tissue structure caused by internal environmental pollution, and the collapse of endogenous immunity and resistance defense make respiratory diseases The phenomenon that the diagnosis is easy but the cure is difficult has not been solved